TipRanks

Samit Hirawat Insider Profile

18 Followers
Samit Hirawat, Director at Pacira Pharmaceuticals, holds 6.41K shares in Pacira Pharmaceuticals (Ticker: PCRX), holds 83.51K shares in Bristol-Myers Squibb (Ticker: BMY).
tipranks
Samit Hirawat

Samit Hirawat
Pacira Pharmaceuticals (PCRX)
Director

Ranked #40,634 out of 109,030 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+8.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
97.18%
2.82%
A breakdown of Samit Hirawat's holdings

Insider Roles

Bristol-Myers Squibb
(BMY)
EVP,Chief Med.Offr.,Drug Dev
Pacira Pharmaceuticals
(PCRX)
Director
Roles that Samit Hirawat holds in companies

Most Profitable Insider Trade

Stock:
Bristol-Myers Squibb
(BMY)
Rating:Informative Buy
Date:Apr 29, 2025 - Apr 29, 2026
Return:+22.80%
The most profitable trade made by Samit Hirawat

Samit Hirawat's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Pacira Pharmaceuticals
Jun 12, 2026
Director
Uninformative Buy
$154.23K
Bristol-Myers Squibb
Apr 29, 2025
EVP,Chief Med.Offr.,Drug Dev
Informative Buy
202.22K
$5.32M
List of latest transactions for each holding click on a transaction to see Samit Hirawat's performance on stock

Samit Hirawat insider profile FAQ

What is the percentage of profitable transactions made by Samit Hirawat?
The percentage of profitable transactions made by Samit Hirawat is 67%.
    What is the average return per transaction made by Samit Hirawat?
    The average return per transaction made by Samit Hirawat is 8.40%.
      What stocks does Samit Hirawat hold?
      Samit Hirawat holds: PCRX, BMY stocks.
        What was Samit Hirawat’s latest transaction?
        Samit Hirawat latest transaction was an Uninformative Buy of ―.
          What was Samit Hirawat's most profitable transaction?
          Samit Hirawat’s most profitable transaction was an Informative Buy of BMY stock on April 29, 2025. The return on the trade was 22.80%.
            What is Samit Hirawat's role in Pacira Pharmaceuticals?
            Samit Hirawat's role in Pacira Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.